Announces updated national, state, and Congressional District polling relevant to priority issues.
The Drug Price Transparency in Medicaid Act will protect patients, pharmacies, and others from middlemen tactics that drive up prescription drug prices.
NACDS President and CEO Steven C. Anderson released the following statement today following the introduction of pharmacy benefit manager (PBM) reform legislation (HB 1509/SB 1550) in the Florida legislature:
Pharmacy benefit manager (PBM) reform; comprehensive direct and indirect remuneration (DIR) fee reform; and sustaining patient access to vaccinations, testing, and treatment among key topics at the February 28-March 1 program.
U.S. House Oversight and Accountability Committee expands bipartisan Congressional push to stop pharmaceutical benefit manipulation by middlemen.
Statement outlines specific solutions to patient-manipulation by “PBMs”.
NACDS stands up for seniors and pharmacies in comments on Medicare proposed rule.
While we all want to move on from COVID-19, doing so should not mean leaving behind millions of Americans who have relied on their trusted, local pharmacies for testing, vaccinations, and care during the pandemic.
Event opens NACDS’ 90th anniversary celebration; brings together pharmacy chains with between four and 250 locations and their supplier partners.
NACDS’ engagement leverages bipartisan momentum for pro-patient, pro-pharmacy PBM reform at state and federal levels.
